Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.

Spring, Laura M

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. [electronic resource] - The oncologist 09 2017 - 1039-1048 p. digital

Publication Type: Journal Article; Review

1549-490X

10.1634/theoncologist.2017-0142 doi


Aminopyridines--pharmacology
Benzimidazoles--pharmacology
Breast Neoplasms--drug therapy
Cell Cycle--drug effects
Clinical Trials as Topic
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Drug Interactions
Female
Humans
Molecular Targeted Therapy--adverse effects
Neutropenia--chemically induced
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Purines--pharmacology
Pyridines--pharmacology